Mehdi Kushkestani, Mohsen Parvani* and Yaser Kazemzadeh
SARS-COV-2 is the novel type of beta coronavirus that was first seen in December 2019 in Wuhan, China. Type 2 Diabetics are one of the groups most vulnerable to SARS-COV-2 and its associated complications. Many factors such as medication, pathophysiologic-induced compensatory mechanisms, and alterations in protein expression and immune system function can all contribute to severe outcomes in diabetics. In this review article, we first described the possible mechanisms of increased risk and more severe complications rate of SARS-COV-2 in diabetic patients. Secondly, we discussed the crucial roles of exercise in diabetic patients and in balancing of RAS system (ACE2/ACE). Finally, we showed the possible roles of acute and chronic exercise in reducing SARS-COV-2 severe outcomes in diabetics in accordance with the latest evidence. We concluded that regular exercise (especially moderate-intensity exercise) can play immune enhancing, anti-inflammatory, anti-oxidation roles and can balance ACE2/ACE ratio (decreasing ANG2 levels) in diabetic subjects.
SARS-COV-2, Diabetes, Angiotensin-Converting Enzyme Inhibitors, Beta-blocker, Exercise, Angiotensin-Converting Enzyme 2, Angiotensin II, Health
Faculty of Physical Education and Sport Sciences, Allameh Tabataba'i University, Tehran, Faculty of Physical Education and Sport Sciences, Allameh Tabataba'i University, Tehran, Faculty of Physical Education and Sport Sciences,Islamshahr branch, Islamic Azad University, Islamshahr